Hematology tests in Dubai & UAE

Compare available Hematology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

114

Listed price range

550.00–7,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hematology test prices

Showing 1–15 of 114 matching tests.

Hematology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-107 Activated Protein C Resistance (APCR) Test This diagnostic test evaluates the body's resistance to activated protein C, a natural anticoagulant.	Whole Blood	Next-day report if sample received by Wednesday 11 AM; otherwise 48h	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Plasma resistance to activated protein C", "Anticoagulant pathway function"] Parameters [{"name": "Activated Protein C Resistance Ratio", "reference_range": null}] Preparation ["Discontinue Heparin for 1 day prior", "Discontinue Oral Anticoagulants for 7 days prior (with physician consent)", "Overnight fasting (8-12 hours) preferred", "Duly filled Coagulation Requisition Form (Form 15) is mandatory"] Indications ["Evaluation of recurrent venous thrombosis risk", "Screening for Factor V Leiden mutation", "Personalized preventive strategy development"] Measurement technique Confirm with laboratory Codes LOINC: 6305-6 ICD-10: D68.5 Clinical summary This diagnostic test evaluates the body's resistance to activated protein C, a natural anticoagulant.
TEST-1871 Acute Leukemia Panel Test This diagnostic test evaluates bone marrow or peripheral blood for the presence and classification of acute leukaemia cells using multiparametric flow cytometry.	Bone marrow aspirate or peripheral blood	1–2 days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leukaemia cell immunophenotype", "Minimal residual disease (MRD)"] Parameters [] Preparation ["Consult with your doctor regarding current medications, especially corticosteroids, immunosuppressants, or anticoagulants.", "Schedule a pre-test consultation to review current therapies."] Indications ["Suspicion of acute leukaemia", "Classification of acute leukaemia (AML, ALL, MPAL)", "Monitoring for minimal residual disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 58491-5 ICD-10: C91.00, C92.00, C95.00 Clinical summary This diagnostic test evaluates bone marrow or peripheral blood for the presence and classification of acute leukaemia cells using multiparametric flow cytometry.
TEST-118 ADAMTS13 Activity Test This diagnostic test evaluates the activity level of the ADAMTS13 enzyme in platelet-poor plasma.	Platelet-poor plasma (sodium citrate)	1 Week (express available)	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ADAMTS13 enzyme activity", "von Willebrand factor-cleaving protease activity"] Parameters [{"name": "ADAMTS13 Activity", "reference_range": "< 10% (indicative of TTP)"}] Preparation ["Overnight fasting is preferred", "Completed Coagulation Requisition Form (Form 15) is mandatory"] Indications ["Suspected Thrombotic Thrombocytopenic Purpura (TTP)", "Differentiation from other thrombotic microangiopathies"] Measurement technique Confirm with laboratory Codes LOINC: 58913-6 ICD-10: M31.1 Clinical summary This diagnostic test evaluates the activity level of the ADAMTS13 enzyme in platelet-poor plasma.
TEST-1866 ALL Panel (Cytogenetics + FISH [BCR/ABL, TEL/AML1, MLL, E2A]) Test This diagnostic test evaluates chromosomal abnormalities and specific gene fusions (BCR/ABL, TEL/AML1, MLL, E2A) associated with acute lymphoblastic leukemia.	Bone marrow aspirate or peripheral blood	10 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal abnormalities (karyotyping)", "Specific gene fusions (BCR/ABL, TEL/AML1, MLL, E2A) via FISH"] Parameters [{"name": "Karyotyping", "reference_range": "Normal human karyotype (46,XX or 46,XY)"}, {"name": "FISH BCR/ABL", "reference_range": "Negative"}, {"name": "FISH TEL/AML1", "reference_range": "Negative"}, {"name": "FISH MLL", "reference_range": "Negative"}, {"name": "FISH E2A", "reference_range": "Negative"}] Preparation ["No specific fasting required", "Inform physician about all current medications"] Indications ["Diagnosis and risk stratification of acute lymphoblastic leukemia", "Guidance for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 53780-4 ICD-10: C91.00 Clinical summary This diagnostic test evaluates chromosomal abnormalities and specific gene fusions (BCR/ABL, TEL/AML1, MLL, E2A) associated with acute lymphoblastic leukemia.
TEST-1862 ALL PCR Panel (BCR‑ABL, TEL‑AML1, MLL, E2A) Test This diagnostic test evaluates for the presence of four specific genetic rearrangements (BCR-ABL, TEL-AML1, MLL, E2A) associated with acute lymphoblastic leukaemia.	Bone marrow aspirate or peripheral blood	5–6 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL rearrangement", "TEL-AML1 rearrangement", "MLL rearrangement", "E2A rearrangement"] Parameters [] Preparation [] Indications ["Diagnosis of acute lymphoblastic leukaemia", "Risk stratification in ALL", "Monitoring minimal residual disease", "Guiding targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 49873-3 ICD-10: C91.00, Z15.01, Z82.79 Clinical summary This diagnostic test evaluates for the presence of four specific genetic rearrangements (BCR-ABL, TEL-AML1, MLL, E2A) associated with acute lymphoblastic leukaemia.
TEST-2214 AML Characterization by Flow Cytometry Immunophenotyping (Leukemia Diagnostic Panel) Test This test evaluates hematopoietic cells using flow cytometry to identify specific surface and cytoplasmic antigens, aiding in the diagnosis, classification, and monitoring of Acute...	Bone Marrow Aspirate (primary), Peripheral Blood (secondary)	Same-day (sample received by 9 AM)	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Surface and cytoplasmic antigens on hematopoietic cells", "Blast percentage", "Aberrant marker expression", "Lineage-defining markers (e.g., CD13, CD33, CD117, HLA-DR, MPO)"] Parameters [{"name": "Blast Percentage", "reference_range": "Variable, depends on clinical context"}, {"name": "Aberrant Antigen Expression", "reference_range": "Variable, depends on clinical context"}, {"name": "Lineage Markers (e.g., CD13, CD33, CD117, HLA-DR, MPO)", "reference_range": "Variable, depends on clinical context"}] Preparation ["No specific patient fasting is required.", "Inform the phlebotomist of all current medications."] Indications ["Diagnosis of suspected Acute Myeloid Leukemia (AML)", "Classification of AML subtypes", "Minimal Residual Disease (MRD) monitoring post-treatment", "Differentiation from other acute leukemias"] Measurement technique Confirm with laboratory Codes LOINC: 48798-3 ICD-10: C92.00 Clinical summary This test evaluates hematopoietic cells using flow cytometry to identify specific surface and cytoplasmic antigens, aiding in the diagnosis, classification, and monitoring of Acute Myeloid Leukemia (AML).
TEST-206 AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor Test This test quantifies the AML1-ETO fusion transcript to monitor minimal residual disease (MRD) in patients with t(8;21) positive AML.	Bone marrow or 5 mL whole blood (Lavender EDTA)	3 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AML1-ETO (RUNX1-RUNX1T1) fusion transcript levels", "Minimal Residual Disease (MRD)"] Parameters [{"name": "AML1-ETO Fusion Transcript Level", "reference_range": "Undetectable (typically < 10⁻⁴ or 10⁻⁵)"}] Preparation [] Indications ["Monitoring response to therapy in t(8;21) positive AML", "Assessing risk of relapse", "Guiding treatment de-escalation decisions"] Measurement technique Confirm with laboratory Codes LOINC: 35076-3 ICD-10: C92.0 Clinical summary This test quantifies the AML1-ETO fusion transcript to monitor minimal residual disease (MRD) in patients with t(8;21) positive AML.
TEST-1845 AML1-ETO (RUNX1::RUNX1T1) FISH Test for AML-M2 This diagnostic test evaluates for the presence of the RUNX1::RUNX1T1 chromosomal translocation in bone marrow cells.	Bone Marrow Aspirate	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RUNX1::RUNX1T1 fusion gene", "Chromosomal translocation t(8;21)(q22;q22)"] Parameters [] Preparation ["No specific fasting required.", "Inform physician of all current medications."] Indications ["Diagnosis of Acute Myeloid Leukaemia (AML)", "Subclassification of AML", "Risk stratification in AML", "Guiding treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 33778-9 ICD-10: C92.0 Clinical summary This diagnostic test evaluates for the presence of the RUNX1::RUNX1T1 chromosomal translocation in bone marrow cells.
TEST-252 Anemia Panel 1 Test This diagnostic test evaluates multiple parameters to determine the type and potential cause of anaemia.	Blood (peripheral whole blood, serum, plasma)	Next day (sample received by 9 AM)	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Complete Blood Count (CBC)", "Serum Iron", "Ferritin", "Vitamin B12", "Folate"] Parameters [{"name": "Complete Blood Count (CBC)", "reference_range": null}, {"name": "Serum Iron", "reference_range": null}, {"name": "Ferritin", "reference_range": null}, {"name": "Vitamin B12", "reference_range": null}, {"name": "Folate", "reference_range": null}] Preparation ["Overnight fasting of 8–12 hours is required.", "Avoid iron supplements for 24 hours prior.", "Avoid coffee, tea, and heavy meals the night before.", "Water is allowed."] Indications ["Suspected iron deficiency anaemia", "Suspected vitamin B12 or folate deficiency anaemia", "Evaluation of unexplained fatigue or weakness", "Monitoring response to anaemia treatment"] Measurement technique Confirm with laboratory Codes LOINC: 57024-2 ICD-10: D50.9 Clinical summary This diagnostic test evaluates multiple parameters to determine the type and potential cause of anaemia.
TEST-254 Anemia Panel 2 Test This diagnostic test evaluates red blood cell parameters, iron status, vitamin levels (B12, Folate), and trace elements (Zinc, Copper) to determine the cause and type of anemia.	Whole Blood & Serum	Next Day (Sample by 6 PM)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Complete Blood Count (CBC) with 5-Part Differential", "Reticulocyte Parameters", "Iron Studies (Serum Iron, TIBC, Ferritin, Transferrin Saturation)", "Vitamin B12", "Folate", "Zinc", "Copper"] Parameters [{"name": "CBC with 5-Part Differential", "reference_range": null}, {"name": "Reticulocyte Count", "reference_range": null}, {"name": "Serum Iron", "reference_range": null}, {"name": "Total Iron Binding Capacity (TIBC)", "reference_range": null}, {"name": "Ferritin", "reference_range": null}, {"name": "Transferrin Saturation", "reference_range": null}, {"name": "Vitamin B12", "reference_range": null}, {"name": "Folate", "reference_range": null}, {"name": "Zinc", "reference_range": null}, {"name": "Copper", "reference_range": null}] Preparation ["Overnight fasting of 8–12 hours is mandatory.", "Morning sampling before 12 noon is preferred.", "Avoid iron-containing supplements for at least 24 hours prior.", "Avoid all food and drink except water during fasting."] Indications ["Unexplained fatigue or weakness", "Suspected iron deficiency anemia", "Suspected vitamin B12 or folate deficiency", "Evaluation of microcytic or macrocytic anemia", "Monitoring response to anemia treatment", "Pre-operative assessment"] Measurement technique Confirm with laboratory Codes LOINC: 24326-1 ICD-10: D64.9 Clinical summary This diagnostic test evaluates red blood cell parameters, iron status, vitamin levels (B12, Folate), and trace elements (Zinc, Copper) to determine the cause and type of anemia.
TEST-3199 ANK1 Gene Spherocytosis Type 1 Genetic Test This test identifies pathogenic variants in the ANK1 gene associated with hereditary spherocytosis type 1.	Peripheral Whole Blood (Venipuncture) or FTA Card (Finger-Prick)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANK1 gene", "Coverage of coding regions and splice sites"] Parameters [] Preparation ["No fasting required", "Inform collector about anticoagulant use"] Indications ["Suspected hereditary spherocytosis", "Family history of hereditary spherocytosis", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21673-3 ICD-10: D58.0 Clinical summary This test identifies pathogenic variants in the ANK1 gene associated with hereditary spherocytosis type 1.
TEST-2894 Antiphospholipid Syndrome (APL) Panel Test This diagnostic test evaluates for the presence of autoantibodies associated with Antiphospholipid Syndrome (APS), a condition linked to increased risk of blood clots and pregnancy...	Peripheral venous blood (serum/plasma)	1 working day (sample by 3 PM, report next day)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Anti-cardiolipin antibodies (IgG, IgM)", "Anti-β2-glycoprotein I antibodies (IgG, IgM)", "Lupus anticoagulant activity (dRVVT)"] Parameters [{"name": "Anti-cardiolipin IgG", "reference_range": null}, {"name": "Anti-cardiolipin IgM", "reference_range": null}, {"name": "Anti-β2-glycoprotein I IgG", "reference_range": null}, {"name": "Anti-β2-glycoprotein I IgM", "reference_range": null}, {"name": "Lupus Anticoagulant (dRVVT)", "reference_range": null}] Preparation ["Fasting overnight is preferred.", "Temporary cessation of heparin (1 day) and oral anticoagulants (7 days) may be required under physician supervision."] Indications ["Evaluation of patients with recurrent thrombosis", "Evaluation of patients with recurrent pregnancy loss", "Investigation of unexplained thrombocytopenia"] Measurement technique Confirm with laboratory Codes LOINC: 53781-0 ICD-10: D68.61, R79.1, O99.11 Clinical summary This diagnostic test evaluates for the presence of autoantibodies associated with Antiphospholipid Syndrome (APS), a condition linked to increased risk of blood clots and pregnancy complications.
TEST-331 Antithrombin Activity Functional Test This test measures the functional activity of antithrombin, a natural anticoagulant protein in the blood.	Citrate Plasma (Blue-top tube)	Same Day (sample received by 11 AM)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Antithrombin activity", "Inhibition of thrombin and factor Xa"] Parameters [{"name": "Antithrombin Activity", "reference_range": null}] Preparation ["Overnight fasting is recommended.", "Temporarily discontinue heparin and oral anticoagulants only under physician guidance."] Indications ["Diagnosis of hereditary antithrombin deficiency", "Diagnosis of acquired antithrombin deficiency", "Evaluation of thrombophilia risk", "Guidance for anticoagulant therapy"] Measurement technique Confirm with laboratory Codes LOINC: 27822-7 ICD-10: D68.52 Clinical summary This test measures the functional activity of antithrombin, a natural anticoagulant protein in the blood.
TEST-324 Antithrombin III Antigen Test This diagnostic test evaluates the quantity of antithrombin III protein in platelet-poor plasma.	Platelet-poor plasma	10–14 business days	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Antithrombin III protein quantity", "Platelet-poor plasma"] Parameters [{"name": "Antithrombin III Antigen", "reference_range": null}] Preparation ["Fast overnight (water allowed)", "Avoid heparin, estrogen-containing drugs, and oral contraceptives for three full days (unless advised otherwise by physician)"] Indications ["Diagnosis of type I hereditary antithrombin deficiency", "Evaluation of acquired thrombophilia", "Guidance for anticoagulant therapy"] Measurement technique Confirm with laboratory Codes LOINC: 44844-7 ICD-10: D68.5 Clinical summary This diagnostic test evaluates the quantity of antithrombin III protein in platelet-poor plasma.
TEST-357 Aspirin Resistance (11‑Dehydrothromboxane B2) Test This diagnostic test evaluates the effectiveness of aspirin therapy by measuring a key metabolite of thromboxane A2 in urine.	Urine	2–3 weeks (sample must be received by the 7th of the month)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["11-Dehydrothromboxane B2 (11-dhTXB2) levels in urine", "Efficacy of aspirin antiplatelet therapy"] Parameters [{"name": "11-Dehydrothromboxane B2", "reference_range": null}] Preparation ["Take aspirin exactly as prescribed.", "Avoid NSAIDs for 48 hours prior to collection.", "Collect morning urine after discarding the first void.", "Complete and return the Test Send Out Consent Form (Form 35) with the sample."] Indications ["Patients on long-term aspirin for cardiovascular protection", "Monitoring aspirin therapy effectiveness"] Measurement technique Confirm with laboratory Codes LOINC: 33960-2 ICD-10: Z79.82 Clinical summary This diagnostic test evaluates the effectiveness of aspirin therapy by measuring a key metabolite of thromboxane A2 in urine.

Category overview

Hematology: overview

When it comes to your circulatory health, finding precise and timely answers is essential for your peace of mind and ongoing vitality. The Hematology department at DNA Labs UAE uses highly advanced flow cytometry and automated cell counters to thoroughly analyze your blood profile. From routine counts to specialized coagulation and hematology testing in the UAE, these diagnostics provide your doctor with crucial data to manage and monitor blood-related conditions effectively. Trust in one of the most reliable diagnostic labs in Dubai and the UAE to deliver fast, highly accurate results under uncompromising confidentiality standards. Ensure your circulatory wellness today. View our hematology tests, arrange a convenient home collection, or contact our medical experts to schedule your visit.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Hematology tests in Dubai & UAE

Hematology test prices

Hematology: overview

Use the test details as a conversation starter

Related Hematology categories